Valiant Laboratories Limited
Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The c… Read more
Market Cap & Net Worth: Valiant Laboratories Limited (VALIANTLAB)
Valiant Laboratories Limited (NSE:VALIANTLAB) has a market capitalization of $5.39K (₹466.87K) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #45943 globally and #2176 in its home market, demonstrating a -8.59% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Valiant Laboratories Limited's stock price ₹50.98 by its total outstanding shares 9158 (9.16K).
Valiant Laboratories Limited Market Cap History: 2025 to 2026
Valiant Laboratories Limited's market capitalization history from 2025 to 2026. Data shows growth from $7.40K to $5.39K (0.00% CAGR).
Valiant Laboratories Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Valiant Laboratories Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Valiant Laboratories Limited's market cap is 0.00 times its annual revenue
1.12x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $7.40K | $1.39 Billion | -$22.01 Million | 0.00x | N/A |
Competitor Companies of VALIANTLAB by Market Capitalization
Companies near Valiant Laboratories Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Valiant Laboratories Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Valiant Laboratories Limited Historical Marketcap From 2025 to 2026
Between 2025 and today, Valiant Laboratories Limited's market cap moved from $7.40K to $ 5.39K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹5.39K | -27.17% |
| 2025 | ₹7.40K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Valiant Laboratories Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.39K USD |
| MoneyControl | $5.39K USD |
| MarketWatch | $5.39K USD |
| marketcap.company | $5.39K USD |
| Reuters | $5.39K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.